ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS
Clinical trials for ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS trials appear
Sign up with your email to follow new studies for ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for kids with rare brain cancer: new drug combo trial launches
Disease control Recruiting nowThis study tests a combination of two drugs, gemcitabine and paxalisib, in children, teens, and young adults whose atypical teratoid rhabdoid tumor (ATRT) has come back or gotten worse. The goal is to find a safe dose and see if the drugs can control the tumor. About 29 participa…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS
Phase: PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Immune cells engineered to hunt brain tumors in kids
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and young adults with medulloblastoma or similar brain tumors that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack tumor cells, deliv…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF THE CNS
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC